Sun Pharmaceutical Industries disclosed a drop in consolidated net profit for the quarter ended September 2015. During the quarter, the profit of the company declined 46.02% to Rs 11,066.60 million from Rs 20,502.20 million in the same quarter previous year.
Revenues for the quarter declined 14.95% to Rs 68,376.10 million, compared with Rs 80,393.70 million for the prior year period.
Operating margin for the quarter stood at 28.28 percent as compared to 38.14 percent for the previous year period. Operating Income for the quarter was Rs 19,337.60 million, compared with Rs 30661.9 million in the previous year period.
Earnings per share for the quarter stood at Rs 4.60, registering 45.88% decline over previous year period.
| Quarterly Results - Consolidated (Rs in mn) |
| As at | Sep - 15 | Sep - 14 | %Change |
| Revenues | 68,376.10 | 80,393.70 | (14.95) |
| Net Profit | 11,066.60 | 20,502.20 | (46.02) |
| Diluted EPS | 4.60 | 8.50 | (45.88) |
Shares of the company declined Rs 48.1, or 5.98%, to trade at Rs 755.60. The total volume of shares traded was 580,517 at the BSE (1.27 p.m., Monday).
